[go: up one dir, main page]

BR9915214A - Combinações contendo um beta-agonista e umagente anti-diabético adicional - Google Patents

Combinações contendo um beta-agonista e umagente anti-diabético adicional

Info

Publication number
BR9915214A
BR9915214A BR9915214-2A BR9915214A BR9915214A BR 9915214 A BR9915214 A BR 9915214A BR 9915214 A BR9915214 A BR 9915214A BR 9915214 A BR9915214 A BR 9915214A
Authority
BR
Brazil
Prior art keywords
agonist
beta
diabetic agent
additional anti
combinations containing
Prior art date
Application number
BR9915214-2A
Other languages
English (en)
Inventor
Jonathan Robert Sanders Arch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9824791.9A external-priority patent/GB9824791D0/en
Priority claimed from GBGB9824790.1A external-priority patent/GB9824790D0/en
Priority claimed from GBGB9824789.3A external-priority patent/GB9824789D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9915214A publication Critical patent/BR9915214A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)

Abstract

"COMBINAçõES CONTENDO UM BETA-AGONISTA E UMAGENTE ANTI-DIABéTICO ADICIONAL". Método para otratamento do diabetes melitus e condições associadas com odiabetes melitus em um mamífero tal como um humano, cujométodo compreende administrar uma quantidade eficaz, não tóxicae farmaceuticamente aceitável de um beta-agonista e um outroagente anti-diabético, a um mamífero com necessidade disto.
BR9915214-2A 1998-11-11 1999-11-11 Combinações contendo um beta-agonista e umagente anti-diabético adicional BR9915214A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9824791.9A GB9824791D0 (en) 1998-11-11 1998-11-11 Novel methods of treatment
GBGB9824790.1A GB9824790D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
GBGB9824789.3A GB9824789D0 (en) 1998-11-11 1998-11-11 Novel method of treatment
PCT/GB1999/003755 WO2000027434A1 (en) 1998-11-11 1999-11-11 Combinations comprising a beta-agonist and a further antidiabetic agent

Publications (1)

Publication Number Publication Date
BR9915214A true BR9915214A (pt) 2001-12-18

Family

ID=27269550

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915214-2A BR9915214A (pt) 1998-11-11 1999-11-11 Combinações contendo um beta-agonista e umagente anti-diabético adicional

Country Status (15)

Country Link
EP (1) EP1128845A1 (pt)
JP (1) JP2002529430A (pt)
KR (1) KR20010075698A (pt)
CN (1) CN1332638A (pt)
AU (1) AU766928B2 (pt)
BR (1) BR9915214A (pt)
CA (1) CA2350062A1 (pt)
CZ (1) CZ20011655A3 (pt)
HK (1) HK1041201A1 (pt)
HU (1) HUP0104388A3 (pt)
IL (1) IL143004A0 (pt)
NO (1) NO20012300L (pt)
PL (1) PL348154A1 (pt)
TR (1) TR200101336T2 (pt)
WO (1) WO2000027434A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007201729B2 (en) * 1999-12-23 2010-02-25 Novartis Ag Use of hypoglycemic agent for treating impaired glucose metabolism
CN1911221A (zh) * 1999-12-23 2007-02-14 诺瓦提斯公司 降血糖剂用于治疗葡萄糖代谢障碍
EP1261373A2 (en) * 1999-12-24 2002-12-04 SmithKline Beecham plc Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
AU2710301A (en) * 2000-01-28 2001-08-07 Asahi Kasei Kabushiki Kaisha Novel remedies with the use of beta3 agonist
WO2001083453A1 (en) * 2000-04-28 2001-11-08 Asahi Kasei Kabushiki Kaisha Novel substituted tricyclic compounds
AU2001252575A1 (en) * 2000-04-28 2001-11-12 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds
WO2006132196A1 (ja) * 2005-06-08 2006-12-14 Asahi Kasei Pharma Corporation β３作動薬を含有する新規な医薬
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69100282T3 (de) * 1990-02-09 2001-01-11 Pharmacia & Upjohn Co., Kalamazoo Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
DE69630319T2 (de) * 1996-01-10 2004-07-29 Asahi Kasei Kabushiki Kaisha Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten

Also Published As

Publication number Publication date
NO20012300L (no) 2001-07-03
AU1063400A (en) 2000-05-29
CN1332638A (zh) 2002-01-23
HUP0104388A3 (en) 2002-12-28
EP1128845A1 (en) 2001-09-05
IL143004A0 (en) 2002-04-21
CA2350062A1 (en) 2000-05-18
PL348154A1 (en) 2002-05-06
HUP0104388A2 (hu) 2002-03-28
NO20012300D0 (no) 2001-05-10
WO2000027434A1 (en) 2000-05-18
KR20010075698A (ko) 2001-08-09
AU766928B2 (en) 2003-10-23
HK1041201A1 (zh) 2002-07-05
CZ20011655A3 (cs) 2002-06-12
JP2002529430A (ja) 2002-09-10
TR200101336T2 (tr) 2001-11-21

Similar Documents

Publication Publication Date Title
SG127714A1 (en) Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
MXPA02012763A (es) Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus.
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
BG104060A (en) Diabetes treatment with thiazolyidindion and methformine
PT1173197E (pt) Intervencao metabolica com glp-1, para melhorar a funcao do tecido isquemico e reperfundido
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
EA200101089A1 (ru) Новый способ лечения
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
BR9810445A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida
BR0012696A (pt) Composição oftálmica
BR9915214A (pt) Combinações contendo um beta-agonista e umagente anti-diabético adicional
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
BR9810292A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase
UY25103A1 (es) Composición para el tratamiento de diabetes mellitus
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
BR9810142A (pt) Tratamento de diabete com tiazolidinadiona e sulfonil-uréia
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물
WO2001045714A3 (en) Formulations of adenosine a1 agonists
BR9915284A (pt) Método de tratamento
KR920702676A (ko) 신규 입체이성질체
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
BR9912144A (pt) Uso de absorsão de glicose como promotor para redução de danos de pós-isquemia do coração
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.